{"transactions":[{"id":725987,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-26T20:52:51.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":5579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $235,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $235,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date."}],"balance_after":5579,"derivative":{"underlying":"Common Stock","underlying_shares":5579},"source":{"system":"sec-edgar","filing":"0000805928-26-000088","document":"wk-form4_1782507169.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000088/wk-form4_1782507169.xml","form_type":"4"}},{"id":729765,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T20:36:22.000Z","date":"2026-06-19","kind":"exercise","planned":false,"acquired":true,"shares":18867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $200,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $200,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":18867},"source":{"system":"sec-edgar","filing":"0000805928-26-000078","document":"wk-form4_1782246978.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000078/wk-form4_1782246978.xml","form_type":"4"}},{"id":729764,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T20:36:22.000Z","date":"2026-06-19","kind":"exercise","planned":false,"acquired":true,"shares":18867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested June 19, 2026."}],"balance_after":32395,"source":{"system":"sec-edgar","filing":"0000805928-26-000078","document":"wk-form4_1782246978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592826000078/wk-form4_1782246978.xml","form_type":"4"}},{"id":742048,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T22:06:26.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":17335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":17335,"derivative":{"exercise_price":0.935,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":17335},"source":{"system":"sec-edgar","filing":"0001166776-26-000002","document":"form4-06112026_100622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1166776/000116677626000002/form4-06112026_100622.xml","form_type":"4"}},{"id":742047,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T22:06:26.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":17550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in 36 equal monthly installments on each monthly anniversary of June 9, 2026, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":17550,"derivative":{"exercise_price":0.935,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":17550},"source":{"system":"sec-edgar","filing":"0001166776-26-000002","document":"form4-06112026_100622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1166776/000116677626000002/form4-06112026_100622.xml","form_type":"4"}},{"id":742046,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T22:06:26.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":11675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":23600,"source":{"system":"sec-edgar","filing":"0001166776-26-000002","document":"form4-06112026_100622.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1166776/000116677626000002/form4-06112026_100622.xml","form_type":"4"}},{"id":742045,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T22:06:26.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":11925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units will vest in three equal annual installments beginning on June 9, 2027, in each case subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":11925,"source":{"system":"sec-edgar","filing":"0001166776-26-000002","document":"form4-06112026_100622.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166776/000116677626000002/form4-06112026_100622.xml","form_type":"4"}},{"id":975257,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-10T22:19:21.000Z","date":"2025-12-09","kind":"sale","planned":false,"acquired":false,"shares":21399,"price":29.614,"value":633709.986,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.56 to $29.70 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":13528,"source":{"system":"sec-edgar","filing":"0000805928-25-000161","document":"wk-form4_1765405158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000161/wk-form4_1765405158.xml","form_type":"4"}},{"id":1105636,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-20T20:07:19.000Z","date":"2025-06-19","kind":"grant","planned":false,"acquired":true,"shares":18867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $200,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $200,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date."}],"balance_after":18867,"derivative":{"underlying":"Common Stock","underlying_shares":18867},"source":{"system":"sec-edgar","filing":"0000805928-25-000096","document":"wk-form4_1750450032.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592825000096/wk-form4_1750450032.xml","form_type":"4"}},{"id":1406057,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T20:14:15.000Z","date":"2024-09-16","kind":"grant","planned":false,"acquired":true,"shares":2875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock in connection with his appointment as Chairman of the Board of Directors."}],"balance_after":34927,"source":{"system":"sec-edgar","filing":"0000805928-24-000131","document":"wk-form4_1726604047.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000131/wk-form4_1726604047.xml","form_type":"4"}},{"id":1416929,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-09-05T00:33:32.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":false,"shares":11904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11904},"source":{"system":"sec-edgar","filing":"0000805928-24-000117","document":"wk-form4_1725494029.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000117/wk-form4_1725494029.xml","form_type":"4"}},{"id":1416928,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-05T00:33:32.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":true,"shares":11904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested on September 1,  2024."}],"balance_after":32052,"source":{"system":"sec-edgar","filing":"0000805928-24-000117","document":"wk-form4_1725494029.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000117/wk-form4_1725494029.xml","form_type":"4"}},{"id":1485713,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2024-06-10T22:19:20.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":18248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 6, 2025, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."}],"balance_after":18248,"derivative":{"exercise_price":7.04,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":18248},"source":{"system":"sec-edgar","filing":"0000805928-24-000097","document":"wk-form4_1718057952.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000097/wk-form4_1718057952.xml","form_type":"4"}},{"id":1485712,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T22:19:20.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":10653,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."}],"balance_after":20148,"source":{"system":"sec-edgar","filing":"0000805928-24-000097","document":"wk-form4_1718057952.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592824000097/wk-form4_1718057952.xml","form_type":"4"}},{"id":1786364,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-09-07T10:30:54.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":11904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units of which shares will be delivered to the reporting person upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units of which shares will be delivered to the reporting person upon vesting."}],"balance_after":11904,"derivative":{"underlying":"Common Stock","underlying_shares":11904},"source":{"system":"sec-edgar","filing":"0000805928-23-000116","document":"wf-form4_169408264223286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000116/wf-form4_169408264223286.xml","form_type":"4"}},{"id":1786363,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to purchase)","published_at":"2023-09-07T10:30:54.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":20436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units of which shares will be delivered to the reporting person upon vesting."}],"balance_after":20436,"derivative":{"exercise_price":6.3,"expiration_date":"2033-09-01","underlying":"Common Stock","underlying_shares":20436},"source":{"system":"sec-edgar","filing":"0000805928-23-000116","document":"wf-form4_169408264223286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000116/wf-form4_169408264223286.xml","form_type":"4"}},{"id":1868339,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-05T22:22:41.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":false,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year from the anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year from the anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6459},"source":{"system":"sec-edgar","filing":"0000805928-23-000058","document":"wf-form4_168600374905379.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000058/wf-form4_168600374905379.xml","form_type":"4"}},{"id":1868338,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T22:22:41.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":true,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested on June 1, 2023."}],"balance_after":9495,"source":{"system":"sec-edgar","filing":"0000805928-23-000058","document":"wf-form4_168600374905379.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000058/wf-form4_168600374905379.xml","form_type":"4"}},{"id":2076394,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 par value","published_at":"2022-12-27T17:21:07.000Z","date":"2022-12-22","kind":"disposition_to_issuer","acquired":false,"shares":6357,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed in connection with transactions contemplated by the Agreement and Plan of Merger, dated as of October 31, 2022 (the \"Merger Agreement\"), by and among the Issuer, Johnson & Johnson (\"Parent\") and Athos Merger Sub, Inc. (\"Merger Sub\"), pursuant to which, on December 22, 2022, Merger Sub was merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each outstanding share of common stock, par value $0.01 per share, of the Issuer (each, an \"Issuer Share\") was automatically converted into the right to receive (i) an amount in cash equal to $380.00 (the \"Cash Amount\"), plus (ii) one non-tradeable contingent value right (the \"CVR\"), representing the right to receive contingent payments of up to $35.00 per Issuer Share, payable upon the achievement of certain specified milestones set out in the Contingent Value Rights Agreement."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, each award of restricted stock units of the Issuer, excluding any award of restricted stock units with vesting subject to performance-based conditions (\"Company RSU Award\"), outstanding as of immediately prior to the Effective Time was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company RSU Award and (B) the Cash Amount and (ii) one CVR per Issuer Share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed in connection with transactions contemplated by the Agreement and Plan of Merger, dated as of October 31, 2022 (the \"Merger Agreement\"), by and among the Issuer, Johnson & Johnson (\"Parent\") and Athos Merger Sub, Inc. (\"Merger Sub\"), pursuant to which, on December 22, 2022, Merger Sub was merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. As a result of the Merger, each outstanding share of common stock, par value $0.01 per share, of the Issuer (each, an \"Issuer Share\") was automatically converted into the right to receive (i) an amount in cash equal to $380.00 (the \"Cash Amount\"), plus (ii) one non-tradeable contingent value right (the \"CVR\"), representing the right to receive contingent payments of up to $35.00 per Issuer Share, payable upon the achievement of certain specified milestones set out in the Contingent Value Rights Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each award of restricted stock units of the Issuer, excluding any award of restricted stock units with vesting subject to performance-based conditions (\"Company RSU Award\"), outstanding as of immediately prior to the Effective Time was canceled and converted into the right to receive (i) an amount in cash, without interest, equal to the product of (A) the aggregate number of Issuer Shares underlying such Company RSU Award and (B) the Cash Amount and (ii) one CVR per Issuer Share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-013000","document":"form4-12272022_101244.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922013000/form4-12272022_101244.xml","form_type":"4"}},{"id":2126521,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 par value","published_at":"2022-11-03T16:50:13.000Z","date":"2022-11-01","kind":"sale","acquired":false,"shares":1000,"price":379.38,"value":379380.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the sale price of the transactions on the reported date at $379.3800. Detailed information regarding the number of shares sold at each separate price willbe provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":6357,"source":{"system":"sec-edgar","filing":"0001415889-22-011063","document":"form4-11032022_011156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922011063/form4-11032022_011156.xml","form_type":"4"}},{"id":2182321,"issuer":{"id":109633,"kind":"organization","name":"SURGALIGN HOLDINGS, INC.","symbol":"SRGA"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T16:47:10.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":22857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock of Surgalign Holdings, Inc. (the \"Company\") granted as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total shares reported reflect 1:30 reverse stock split on May 17, 2022."}],"balance_after":28610,"source":{"system":"sec-edgar","filing":"0001209191-22-046168","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166776/000120919122046168/doc4.xml","form_type":"4"}},{"id":2187509,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 par value","published_at":"2022-08-12T16:10:29.000Z","date":"2022-08-11","kind":"tax_withholding","acquired":false,"shares":232,"price":293.34,"value":68054.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F2","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":7357,"source":{"system":"sec-edgar","filing":"0001415889-22-008531","document":"form4-08122022_010818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922008531/form4-08122022_010818.xml","form_type":"4"}},{"id":2187508,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 par value","published_at":"2022-08-12T16:10:29.000Z","date":"2022-08-10","kind":"grant","acquired":true,"shares":681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) the first anniversary of the date of grant; and (b) the date of the Corporation's 2023 Annual Meeting; that such awards shall be subject to a Time-Based Restricted Stock Unit Award Agreement in accordance with the Second Amended & Restated 2015 Omnibus Incentive Plan"},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) the first anniversary of the date of grant; and (b) the date of the Corporation's 2023 Annual Meeting; that such awards shall be subject to a Time-Based Restricted Stock Unit Award Agreement in accordance with the Second Amended & Restated 2015 Omnibus Incentive Plan"}],"balance_after":7589,"source":{"system":"sec-edgar","filing":"0001415889-22-008531","document":"form4-08122022_010818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000141588922008531/form4-08122022_010818.xml","form_type":"4"}},{"id":2246243,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-03T20:16:15.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."}],"balance_after":6459,"derivative":{"underlying":"Common Stock","underlying_shares":6459},"source":{"system":"sec-edgar","filing":"0000805928-22-000069","document":"wf-form4_165428734992822.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000069/wf-form4_165428734992822.xml","form_type":"4"}},{"id":2246242,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2022-06-03T20:16:15.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":11811,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."}],"balance_after":11811,"derivative":{"exercise_price":9.29,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":11811},"source":{"system":"sec-edgar","filing":"0000805928-22-000069","document":"wf-form4_165428734992822.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000069/wf-form4_165428734992822.xml","form_type":"4"}},{"id":2246241,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-03T20:16:15.000Z","date":"2022-06-01","kind":"exercise","acquired":false,"shares":3036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3036},"source":{"system":"sec-edgar","filing":"0000805928-22-000069","document":"wf-form4_165428734992822.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000069/wf-form4_165428734992822.xml","form_type":"4"}},{"id":2246240,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T20:16:15.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":3036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects the number of restricted stock units that vested on June 1, 2022."}],"balance_after":3036,"source":{"system":"sec-edgar","filing":"0000805928-22-000069","document":"wf-form4_165428734992822.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592822000069/wf-form4_165428734992822.xml","form_type":"4"}},{"id":2596816,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 par value","published_at":"2021-08-19T16:17:18.000Z","date":"2021-08-18","kind":"sale","acquired":false,"shares":663,"price":330.77,"value":219300.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the sale price of the transactions on the reported date at $330.7687. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":6908,"source":{"system":"sec-edgar","filing":"0001179110-21-008306","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021008306/edgar.xml","form_type":"4"}},{"id":2604581,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 par value","published_at":"2021-08-13T16:30:54.000Z","date":"2021-08-12","kind":"tax_withholding","acquired":false,"shares":245,"price":319.88,"value":78370.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F2","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":7571,"source":{"system":"sec-edgar","filing":"0001179110-21-008178","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021008178/edgar.xml","form_type":"4"}},{"id":2604580,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 par value","published_at":"2021-08-13T16:30:54.000Z","date":"2021-08-11","kind":"grant","acquired":true,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 11, 2022; or (b) the date of the Issuer's next annual meeting of stockholders."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 11, 2022; or (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":7816,"source":{"system":"sec-edgar","filing":"0001179110-21-008178","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911021008178/edgar.xml","form_type":"4"}},{"id":2645384,"issuer":{"id":109633,"kind":"organization","name":"SURGALIGN HOLDINGS, INC.","symbol":"SRGA"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T20:52:01.000Z","date":"2021-05-07","kind":"grant","acquired":true,"shares":72254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Form 4 filed on 5/10/2021 representing restricted stock units of Surgalign Holdings, Inc. (the \"Company\") granted as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant erroneously reported 57,803 RSUs in column four. The purpose of this amendment is to correct the total underlying shares in columns four and five."}],"balance_after":172669,"source":{"system":"sec-edgar","filing":"0001209191-21-045030","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166776/000120919121045030/doc4a.xml","form_type":"4/A","original_submission_date":"2021-05-10"}},{"id":2684918,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-03T21:14:54.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":3036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."}],"balance_after":3036,"derivative":{"underlying":"Common Stock","underlying_shares":3036},"source":{"system":"sec-edgar","filing":"0000805928-21-000112","document":"wf-form4_162275486446760.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000112/wf-form4_162275486446760.xml","form_type":"4"}},{"id":2684917,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-03T21:14:54.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":6030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units."}],"balance_after":6030,"derivative":{"exercise_price":19.76,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":6030},"source":{"system":"sec-edgar","filing":"0000805928-21-000112","document":"wf-form4_162275486446760.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000080592821000112/wf-form4_162275486446760.xml","form_type":"4"}},{"id":2721241,"issuer":{"id":109633,"kind":"organization","name":"SURGALIGN HOLDINGS, INC.","symbol":"SRGA"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-10T21:28:15.000Z","date":"2021-05-07","kind":"grant","acquired":true,"shares":57803,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units of Surgalign Holdings, Inc. (the \"Company\") granted as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant."}],"balance_after":158218,"source":{"system":"sec-edgar","filing":"0001209191-21-031336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166776/000120919121031336/doc4.xml","form_type":"4"}},{"id":3017470,"issuer":{"id":4297,"kind":"organization","name":"Axogen, Inc.","symbol":"AXGN"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2020-10-02T20:10:38.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":45910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option grant for joining the Issuer's Board of Directors. Options vest annually in equal parts over a three year period and become fully vested on September 30, 2023"}],"balance_after":45910,"derivative":{"exercise_price":11.63,"expiration_date":"2030-09-30","underlying":"Common Stock","underlying_shares":45910},"source":{"system":"sec-edgar","filing":"0001179110-20-010142","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/805928/000117911020010142/edgar.xml","form_type":"4"}},{"id":3057852,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 par value","published_at":"2020-08-14T16:12:40.000Z","date":"2020-08-12","kind":"grant","acquired":true,"shares":661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 12, 2021; or (b) the date of the Issuer's next annual meeting of stockholders."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 12, 2021; or (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":7191,"source":{"system":"sec-edgar","filing":"0001179110-20-009050","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020009050/edgar.xml","form_type":"4"}},{"id":3062582,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 par value","published_at":"2020-08-11T16:07:15.000Z","date":"2020-08-10","kind":"sale","acquired":false,"shares":2000,"price":303.41,"value":606820.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price represents the sale price of the transactions on the reported date at $303.413. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":6530,"source":{"system":"sec-edgar","filing":"0001179110-20-008872","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020008872/edgar.xml","form_type":"4"}},{"id":3062581,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 par value","published_at":"2020-08-11T16:07:15.000Z","date":"2020-08-07","kind":"tax_withholding","acquired":false,"shares":390,"price":314.98,"value":122842.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":8530,"source":{"system":"sec-edgar","filing":"0001179110-20-008872","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020008872/edgar.xml","form_type":"4"}},{"id":3229572,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 par value","published_at":"2020-03-04T16:23:53.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":2000,"price":151.7806,"value":303561.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average sale price of multiple transactions on the reported date at a price of $151.7806. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":8920,"source":{"system":"sec-edgar","filing":"0001179110-20-003080","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020003080/edgar.xml","form_type":"4"}},{"id":3238589,"issuer":{"id":109633,"kind":"organization","name":"SURGALIGN HOLDINGS, INC.","symbol":"SRGA"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-02T18:42:09.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":24692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock of RTI Surgical Holdings, Inc. (the \"Company\") granted to Mr. Thomas as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant."}],"balance_after":100415,"source":{"system":"sec-edgar","filing":"0001209191-20-014372","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166776/000120919120014372/doc4.xml","form_type":"4"}},{"id":3278361,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 par value","published_at":"2020-02-12T17:14:11.000Z","date":"2020-02-10","kind":"sale","acquired":false,"shares":2000,"price":181.1252,"value":362250.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price represents the weighted average sale price of multiple transactions on the reported date at a price of $181.1252. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer."}],"balance_after":10920,"source":{"system":"sec-edgar","filing":"0001179110-20-001520","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911020001520/edgar.xml","form_type":"4"}},{"id":3442884,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 par value","published_at":"2019-08-09T16:38:51.000Z","date":"2019-08-08","kind":"tax_withholding","acquired":false,"shares":245,"price":189.93,"value":46532.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F2","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":12920,"source":{"system":"sec-edgar","filing":"0001179110-19-009349","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911019009349/edgar.xml","form_type":"4"}},{"id":3442883,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 par value","published_at":"2019-08-09T16:38:51.000Z","date":"2019-08-07","kind":"grant","acquired":true,"shares":1053,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 7, 2020; or (b) the date of the Issuer's next annual meeting of stockholders."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 7, 2020; or (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":13165,"source":{"system":"sec-edgar","filing":"0001179110-19-009349","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911019009349/edgar.xml","form_type":"4"}},{"id":3602422,"issuer":{"id":109633,"kind":"organization","name":"SURGALIGN HOLDINGS, INC.","symbol":"SRGA"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-11T17:32:26.000Z","date":"2019-03-08","kind":"grant","acquired":true,"shares":75723,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 8, 2019, pursuant to the Master Transaction Agreement, by and among the Issuer, RTI Surgical, Inc., a Delaware corporation (\"Old RTI\"), PS Spine Holdco, LLC, a Delaware limited liability company (the \"Member\"), and Bears Merger Sub, Inc., a Delaware corporation (the \"Merger Sub\"): (a) the Merger Sub merged with and into Old RTI, with Old RTI surviving as a wholly-owned subsidiary of the Issuer (the \"Merger\"); (b) the Member contributed all of the issued and outstanding membership interests of Paradigm Spine, LLC, a Delaware limited liability company and wholly owned subsidiary of the Member, to the Issuer; and (c) the Issuer was renamed \"RTI Surgical Holdings, Inc.\""},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Master Transaction Agreement, at the effective time of the Merger: (a) each issued and outstanding share of common stock of Old RTI converted automatically into one share of the Issuer's common stock; (b) each issued and outstanding share of Series A Convertible Preferred Stock of Old RTI converted automatically into one share of the Issuer's Series A Convertible Preferred Stock; and (c) each stock option and restricted stock award granted by Old RTI converted into a stock option or restricted stock award, as applicable, of the Issuer with respect to an equivalent number of shares of the Issuer's common stock on the same terms and conditions as were applicable prior to the Closing. This report reflects the beneficial ownership of the reporting person at the time of the consummation of the Merger and does not include the securities of the Issuer acquired by the reporting person upon the consummation of the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Total includes 21,322 shares of restricted stock that will vest on 2/26/2020."}],"balance_after":75723,"source":{"system":"sec-edgar","filing":"0001760173-19-000023","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166776/000176017319000023/primary_doc.xml","form_type":"4"}},{"id":3602624,"issuer":{"id":159205,"kind":"organization","name":"RTI SURGICAL, INC.","symbol":"RTIX"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-11T13:26:05.000Z","date":"2019-03-08","kind":"disposition_to_issuer","acquired":false,"shares":75723,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 8, 2019, pursuant to the Master Transaction Agreement, by and among the Issuer, RTI Surgical, Inc., a Delaware corporation (\"Old RTI\"), PS Spine Holdco, LLC, a Delaware limited liability company (the \"Member\"), and Bears Merger Sub, Inc., a Delaware corporation (the \"Merger Sub\"): (a) the Merger Sub merged with and into Old RTI, with Old RTI surviving as a wholly-owned subsidiary of the Issuer (the \"Merger\"); (b) the Member contributed all of the issued and outstanding membership interests of Paradigm Spine, LLC, a Delaware limited liability company and wholly owned subsidiary of the Member, to the Issuer; and (c) the Issuer was renamed \"RTI Surgical Holdings, Inc.\""},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Master Transaction Agreement, at the effective time of the Merger: (a) each issued and outstanding share of common stock of Old RTI converted automatically into one share of the Issuer's common stock; (b) each issued and outstanding share of Series A Convertible Preferred Stock of Old RTI converted automatically into one share of the Issuer's Series A Convertible Preferred Stock; and (c) each stock option and restricted stock award granted by Old RTI converted into a stock option or restricted stock award, as applicable, of the Issuer with respect to an equivalent number of shares of the Issuer's common stock on the same terms and conditions as were applicable prior to the Closing. This report reflects the beneficial ownership of the reporting person at the time of the consummation of the Merger and does not include the securities of the Issuer acquired by the reporting person upon the consummation of the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person will file a Form 4 reflecting his acquisition of the Issuer's securities in connection with the consummation of the Mergers."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Total includes 21,322 shares of restricted stock that will vest on 2/26/2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001100441-19-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100441/000110044119000009/primary_doc.xml","form_type":"4"}},{"id":3629528,"issuer":{"id":159205,"kind":"organization","name":"RTI SURGICAL, INC.","symbol":"RTIX"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-27T14:55:11.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":21322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock of RTI Surgical, Inc.(the \"Company\") granted to Mr. Thomas as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant."}],"balance_after":75723,"source":{"system":"sec-edgar","filing":"0001100441-19-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100441/000110044119000002/primary_doc.xml","form_type":"4"}},{"id":3847939,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 par value","published_at":"2018-08-10T20:11:55.000Z","date":"2018-08-08","kind":"tax_withholding","acquired":false,"shares":591,"price":376.01,"value":222221.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."},{"field":"shares","element":"transactionShares","label":"F2","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards."}],"balance_after":12112,"source":{"system":"sec-edgar","filing":"0001179110-18-010522","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911018010522/edgar.xml","form_type":"4"}},{"id":3847938,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 par value","published_at":"2018-08-10T20:11:55.000Z","date":"2018-08-08","kind":"grant","acquired":true,"shares":531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 8, 2019; or (b) the date of the Issuer's next annual meeting of stockholders."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the earlier of: (a) August 8, 2019; or (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":12703,"source":{"system":"sec-edgar","filing":"0001179110-18-010522","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911018010522/edgar.xml","form_type":"4"}},{"id":4024627,"issuer":{"id":159205,"kind":"organization","name":"RTI SURGICAL, INC.","symbol":"RTIX"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-01T13:11:36.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":17647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock of RTI Surgical, Inc. (the \"Company\") granted to Mr. Thomas as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant."}],"balance_after":54401,"source":{"system":"sec-edgar","filing":"0001100441-18-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100441/000110044118000003/primary_doc.xml","form_type":"4"}},{"id":4231654,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 par value","published_at":"2017-08-17T16:22:52.000Z","date":"2017-08-15","kind":"sale","acquired":false,"shares":10000,"price":154.7075,"value":1547075.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."},{"field":"shares","element":"transactionShares","label":"F1","text":"Sale of common stock pursuant to reporting owner's 10b5-1 plan."}],"balance_after":12172,"source":{"system":"sec-edgar","filing":"0001179110-17-011618","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911017011618/edgar.xml","form_type":"4"}},{"id":4234612,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 par value","published_at":"2017-08-15T16:06:45.000Z","date":"2017-08-13","kind":"tax_withholding","acquired":false,"shares":1254,"price":151.37,"value":189817.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with vesting of awards of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with vesting of awards of restricted stock units."}],"balance_after":22172,"source":{"system":"sec-edgar","filing":"0001179110-17-011491","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911017011491/edgar.xml","form_type":"4"}},{"id":4237094,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 par value","published_at":"2017-08-11T16:12:03.000Z","date":"2017-08-09","kind":"tax_withholding","acquired":false,"shares":787,"price":155.87,"value":122669.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with vesting of awards of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F2","text":"Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with vesting of awards of restricted stock units."}],"balance_after":23426,"source":{"system":"sec-edgar","filing":"0001179110-17-011396","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911017011396/edgar.xml","form_type":"4"}},{"id":4237093,"issuer":{"id":121309,"kind":"organization","name":"ABIOMED INC","symbol":"NASD"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 par value","published_at":"2017-08-11T16:12:03.000Z","date":"2017-08-09","kind":"grant","acquired":true,"shares":1283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the later of: (a) August 9, 2018; or (b) the date of the Issuer's next annual meeting of stockholders."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the grant of restricted stock units that are to be settled in common stock upon vesting. The restricted stock units will vest in full on the later of: (a) August 9, 2018; or (b) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":24213,"source":{"system":"sec-edgar","filing":"0001179110-17-011396","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/815094/000117911017011396/edgar.xml","form_type":"4"}},{"id":4316240,"issuer":{"id":159205,"kind":"organization","name":"RTI SURGICAL, INC.","symbol":"RTIX"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-17T14:24:19.000Z","date":"2017-05-16","kind":"grant","acquired":true,"shares":16484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock of RTI Surgical, Inc. (the \"Company\") granted to Mr. Thomas as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant."}],"balance_after":36754,"source":{"system":"sec-edgar","filing":"0001100441-17-000013","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100441/000110044117000013/primary_doc.xml","form_type":"4"}},{"id":4538946,"issuer":{"id":180735,"kind":"organization","name":"Aegerion Pharmaceuticals, Inc.","symbol":"AEGR"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-01T00:50:34.000Z","date":"2016-11-29","kind":"disposition_to_issuer","acquired":false,"shares":18000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the merger, each option to acquire common stock of the Issuer that was outstanding and unexercised immediately prior to the effective time of the merger that had an exercise price per share equal to or greater than $1.88 (the product obtained by multiplying (i) the exchange ratio of 1.0256 by (ii) $1.83, the closing price of a common share of QLT on November 28, 2016) was cancelled without any payment or other consideration therefor."}],"balance_after":0,"derivative":{"exercise_price":17.98,"exercise_date":"2016-06-26","expiration_date":"2025-06-26","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001104659-16-159827","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1166776/000110465916159827/a4.xml","form_type":"4"}},{"id":4538945,"issuer":{"id":180735,"kind":"organization","name":"Aegerion Pharmaceuticals, Inc.","symbol":"AEGR"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-01T00:50:34.000Z","date":"2016-11-29","kind":"disposition_to_issuer","acquired":false,"shares":5012,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the merger, each option to acquire common stock of the Issuer that was outstanding and unexercised immediately prior to the effective time of the merger that had an exercise price per share equal to or greater than $1.88 (the product obtained by multiplying (i) the exchange ratio of 1.0256 by (ii) $1.83, the closing price of a common share of QLT on November 28, 2016) was cancelled without any payment or other consideration therefor."}],"balance_after":0,"derivative":{"exercise_price":32.55,"exercise_date":"2015-06-26","expiration_date":"2024-06-26","underlying":"Common Stock","underlying_shares":5012},"source":{"system":"sec-edgar","filing":"0001104659-16-159827","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1166776/000110465916159827/a4.xml","form_type":"4"}},{"id":4538944,"issuer":{"id":180735,"kind":"organization","name":"Aegerion Pharmaceuticals, Inc.","symbol":"AEGR"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-01T00:50:34.000Z","date":"2016-11-29","kind":"disposition_to_issuer","acquired":false,"shares":14700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the merger, each option to acquire common stock of the Issuer that was outstanding and unexercised immediately prior to the effective time of the merger that had an exercise price per share equal to or greater than $1.88 (the product obtained by multiplying (i) the exchange ratio of 1.0256 by (ii) $1.83, the closing price of a common share of QLT on November 28, 2016) was cancelled without any payment or other consideration therefor."}],"balance_after":0,"derivative":{"exercise_price":64.73,"exercise_date":"2014-06-26","expiration_date":"2023-06-26","underlying":"Common Stock","underlying_shares":14700},"source":{"system":"sec-edgar","filing":"0001104659-16-159827","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1166776/000110465916159827/a4.xml","form_type":"4"}},{"id":4538943,"issuer":{"id":180735,"kind":"organization","name":"Aegerion Pharmaceuticals, Inc.","symbol":"AEGR"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-01T00:50:34.000Z","date":"2016-11-29","kind":"disposition_to_issuer","acquired":false,"shares":12854,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the merger, each option to acquire common stock of the Issuer that was outstanding and unexercised immediately prior to the effective time of the merger that had an exercise price per share equal to or greater than $1.88 (the product obtained by multiplying (i) the exchange ratio of 1.0256 by (ii) $1.83, the closing price of a common share of QLT on November 28, 2016) was cancelled without any payment or other consideration therefor."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2015-06-05","expiration_date":"2022-06-05","underlying":"Common Stock","underlying_shares":12854},"source":{"system":"sec-edgar","filing":"0001104659-16-159827","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1166776/000110465916159827/a4.xml","form_type":"4"}},{"id":4538942,"issuer":{"id":180735,"kind":"organization","name":"Aegerion Pharmaceuticals, Inc.","symbol":"AEGR"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-01T00:50:34.000Z","date":"2016-11-29","kind":"disposition_to_issuer","acquired":false,"shares":23521,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the merger, each option to acquire common stock of the Issuer that was outstanding and unexercised immediately prior to the effective time of the merger that had an exercise price per share equal to or greater than $1.88 (the product obtained by multiplying (i) the exchange ratio of 1.0256 by (ii) $1.83, the closing price of a common share of QLT on November 28, 2016) was cancelled without any payment or other consideration therefor."}],"balance_after":0,"derivative":{"exercise_price":15.26,"exercise_date":"2015-08-01","expiration_date":"2021-08-01","underlying":"Common Stock","underlying_shares":23521},"source":{"system":"sec-edgar","filing":"0001104659-16-159827","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1166776/000110465916159827/a4.xml","form_type":"4"}},{"id":4538941,"issuer":{"id":180735,"kind":"organization","name":"Aegerion Pharmaceuticals, Inc.","symbol":"AEGR"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-01T00:50:34.000Z","date":"2016-11-29","kind":"disposition_to_issuer","acquired":false,"shares":36978,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of in exchange for 37,924 common shares of Novelion Therapeutics Inc. pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of June 14, 2016, by and among the Issuer, QLT Inc. (\"QLT\") and Isotope Acquisition Corp. (\"Isotope\"), pursuant to which Isotope was merged with and into the Issuer, effective November 29, 2016. Following completion of the merger, QLT was renamed \"Novelion Therapeutics Inc.\""}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-16-159827","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166776/000110465916159827/a4.xml","form_type":"4"}},{"id":4560778,"issuer":{"id":172682,"kind":"organization","name":"Roka BioScience, Inc.","symbol":"ROKA"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Series A Convertible Preferred Stock","published_at":"2016-11-10T21:16:16.000Z","date":"2016-11-10","kind":"exercise","acquired":false,"shares":50,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reporting person's Series A Convertible Preferred Stock, par value $0.001 per share (the \"Series A Preferred Shares\")  automatically converted into shares of the Company's common stock, par value $0.001 (the \"Common Shares\") at a conversion price of $7.00 per share resulting in his acquisition of 7,143 Common Shares.  Common Shares disclosed reflect the October 11, 2016, 10 for 1 reverse stock split of the Company's Common Shares.  The Series A Preferred Shares were adjusted proportionately and consequently, each share of Preferred Stock became convertible into approximately 143 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Preferred Shares automatically converted, upon receipt of Company shareholder approval and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Preferred Shares automatically converted, upon receipt of Company shareholder approval and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common stock, par value $0.001 per share","underlying_shares":7143},"source":{"system":"sec-edgar","filing":"0001472343-16-000237","document":"wf-form4_147881256273286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1166776/000147234316000237/wf-form4_147881256273286.xml","form_type":"4"}},{"id":4560777,"issuer":{"id":172682,"kind":"organization","name":"Roka BioScience, Inc.","symbol":"ROKA"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock, par value $0.001 per share","published_at":"2016-11-10T21:16:16.000Z","date":"2016-11-10","kind":"exercise","acquired":true,"shares":7143,"price":7,"value":50001.0,"ownership":{"direct":true},"balance_after":85494,"source":{"system":"sec-edgar","filing":"0001472343-16-000237","document":"wf-form4_147881256273286.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166776/000147234316000237/wf-form4_147881256273286.xml","form_type":"4"}},{"id":4596338,"issuer":{"id":172682,"kind":"organization","name":"Roka BioScience, Inc.","symbol":"ROKA"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Warrant (right to buy)","published_at":"2016-09-23T20:30:25.000Z","date":"2016-09-21","kind":"purchase","acquired":true,"shares":71429,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person purchased 50 Series A Preferred Shares and five-year warrants to purchase 71,429 Common Shares at a purchase price of $1,000 per share pursuant to a private offering of the Company for a total of $50,000."}],"balance_after":71429,"derivative":{"exercise_price":0.7,"exercise_date":"2016-09-21","expiration_date":"2021-09-21","underlying":"Common stock, par value $0.001 per share","underlying_shares":71429},"source":{"system":"sec-edgar","filing":"0001472343-16-000194","document":"wf-form4_147466261183235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1166776/000147234316000194/wf-form4_147466261183235.xml","form_type":"4"}},{"id":4596337,"issuer":{"id":172682,"kind":"organization","name":"Roka BioScience, Inc.","symbol":"ROKA"},"owners":[{"id":35286,"kind":"person","name":"THOMAS PAUL","position":1,"cik":"0001166776","reported_name":"THOMAS PAUL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Series A Convertible Preferred Stock","published_at":"2016-09-23T20:30:25.000Z","date":"2016-09-21","kind":"purchase","acquired":true,"shares":50,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person purchased 50 Series A Preferred Shares and five-year warrants to purchase 71,429 Common Shares at a purchase price of $1,000 per share pursuant to a private offering of the Company for a total of $50,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock and the lock up agreement dated September 21, 2016, reporting person's Series A Convertible Preferred Stock, par value $0.001 per share (the \"Series A Preferred Shares\")  automatically converts, upon receipt by the Company of shareholder approval, into shares of the Company's common stock, par value $0.001 (the \"Common Shares\") at a conversion price of $0.70 per share. The Series A Preferred Shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms of the Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock and the lock up agreement dated September 21, 2016, reporting person's Series A Convertible Preferred Stock, par value $0.001 per share (the \"Series A Preferred Shares\")  automatically converts, upon receipt by the Company of shareholder approval, into shares of the Company's common stock, par value $0.001 (the \"Common Shares\") at a conversion price of $0.70 per share. The Series A Preferred Shares have no expiration date."}],"balance_after":50,"derivative":{"exercise_price":0.7,"underlying":"Common stock, par value $0.001 per share","underlying_shares":50},"source":{"system":"sec-edgar","filing":"0001472343-16-000194","document":"wf-form4_147466261183235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166776/000147234316000194/wf-form4_147466261183235.xml","form_type":"4"}}]}